Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand
Completed
- Conditions
- Asthma
- Registration Number
- NCT00800904
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual clinical practice. Such percentage for each level of severity - mild, moderate and severe persistent asthma as well as the differences of these rates will also be explored.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1210
Inclusion Criteria
- Established persistent asthma
- Currently treated with any inhaled corticosteroid therapy but not SYMBICORT nor SERETIDE for 3 months or longer
Exclusion Criteria
- Currently participating or have participated in a study with an investigational compound within the last 30 days
- Current diagnosis of chronic obstructive pulmonary disease (COPD)
- Smoked more than 10 packs a year
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Asthma control test On the survey date
- Secondary Outcome Measures
Name Time Method Asthma control in mild, moderate and severe persistent asthma patients On the survey date
Trial Locations
- Locations (1)
Research Site
🇹🇭Yasothon, Thailand